← All organizations

Medicines360

Academic/Hospital

Also known as: Medicines360 | MEDICINES360

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

First marketed drug

Last known activity

Oct 1, 2018

Timeline

2010s

Feb 26, 2015
norgestrel— NDA Secondary Org

Drugs by trial phase (2 distinct, 2 trials)

Phase 3 (2 own, 0 via acquisition)

Indications

Studied for

Menorrhagia

Marketed drugs (1)

norgestrel

Recent trials (2)

NCT03642210Lead sponsorPhase 3Oct 1, 2018
NCT00995150Lead sponsorPhase 3Nov 1, 2009

Details

Last known activity: Oct 1, 2018